Author

Tone Bergene Aabrekk

Observed names: Aabrekk, Tone Bergene, T B Aabrekk, T Bergene Aabrekk, Tone Aabrekk, Tone B Aabrekk, Tone B. Aabrekk, Tone Bergene Aaabrekke

Institutions: University of Oslo, Sykehuset i Vestfold

Observed institutions: University of Oslo, Sykehuset i Vestfold

ORCID: 0009-0007-4933-5580

Observed ORCID: 0009-0007-4933-5580

OpenAlex ID: A5057863238

Inflammatory bowel disease in South-Eastern Norway III (IBSEN III): a new population-based inception cohort study from South-Eastern Norway

2021 · Vendel A. Kristensen, Randi Opheim, et al. · Scandinavian Journal of Gastroenterology · 36

PDF

Fatigue in Patients with Newly Diagnosed Inflammatory Bowel Disease: Results from a Prospective Inception Cohort, the IBSEN III Study

2023 · Kristina I Aass Holten, Tomm Bernklev, et al. · Journal of Crohn s and Colitis · 33

PDF

Symptoms and symptom clusters in patients newly diagnosed with inflammatory bowel disease: results from the IBSEN III Study

2023 · Ingunn Johansen, Milada Cvancarova Småstuen, et al. · BMC Gastroenterology · 24

PDF

2023 · Bjorn Christian Olsen, Randi Opheim, et al. · Quality of Life Research · 17

PDF

Anti-integrin αvβ6 IgG antibody as a diagnostic and prognostic marker in ulcerative colitis: A cross-sectional and longitudinal study defining a specific disease phenotype

2025 · Eleftheria Pertsinidou, Benita Salomon, et al. · Journal of Crohn s and Colitis · 12

PDF

Fatigue in Patients with Inflammatory Bowel Disease in Remission One Year After Diagnosis (the IBSEN III Study)

2024 · Kristina A Holten, Tomm Bernklev, et al. · Journal of Crohn s and Colitis · 11

Clinical course of ulcerative colitis: Frequent use of biologics and low colectomy rate first year after diagnosis—results from the IBSEN III inception cohort

2024 · Vibeke Strande, Charlotte Lund, et al. · Alimentary Pharmacology & Therapeutics · 11

Prevalence of Irritable Bowel Syndrome Based on Rome IV Criteria in Patients in Biochemical and Endoscopic Remission From Newly Diagnosed Inflammatory Bowel Disease: One- and Three-Year Results (the IBSEN III Cohort)

2025 · Bjorn Christian Olsen, Randi Opheim, et al. · Inflammatory Bowel Diseases · 10

Dietary intake and nutritional status in patients with newly diagnosed inflammatory bowel disease: insights from the IBSEN III study

2024 · Insaf Zerouga, Jørgen Valeur, et al. · Scandinavian Journal of Gastroenterology · 7

Low Surgery Rates in Early Crohn’s Disease: Results from a Prospective Population-Based Inception Cohort—The Inflammatory Bowel Disease in South-Eastern Norway III Study

2024 · Charlotte Lund, Vibeke Strande, et al. · Inflammatory Bowel Diseases · 6

PDF

Fecal Microbiome Reflects Disease State and Prognosis in Inflammatory Bowel Disease in an Adult Population-Based Inception Cohort

2025 · Simen Hyll Hansen, Maria Gjerstad Maseng, et al. · Inflammatory Bowel Diseases · 5

PDF

Simultaneous profiling of the blood and gut T and B cell repertoires in Crohn’s disease and symptomatic controls illustrates tissue-specific alterations in the immune repertoire of individuals with Crohn’s disease

2025 · Aya K. H. Mahdy, Valentina Schöpfel, et al. · Frontiers in Immunology · 4

PDF

Predicting severe inflammatory bowel disease: a risk matrix model based on the IBSEN III inception cohort

2025 · Vibeke Strande, Milada Hagen, et al. · Scandinavian Journal of Gastroenterology · 4

P154 A novel serum protein signature as biomarker for Inflammatory Bowel Disease: A diagnostic performance and prediction modelling study using data from two independent inception cohorts

2023 · I Bazov, R Kruse, et al. · Journal of Crohn s and Colitis · 4

Habitual intake of macronutrients and fermentable oligo-, di-, monosaccharides and polyols is not associated with irritable bowel syndrome-like symptoms in inflammatory bowel disease

2025 · Insaf Zerouga, Jørgen Valeur, et al. · Clinical Nutrition ESPEN · 3

PDF

P816 IBSEN III—a new population-based inception cohort from South-Eastern Norway

2018 · V A Kristensen, R Opheim, et al. · Journal of Crohn s and Colitis · 3

Anxiety and depression in newly diagnosed patients with inflammatory bowel disease (the IBSEN III study) compared with the general population in Norway

2026 · Ingunn Johansen, Milada C Hagen, et al. · Journal of Crohn s and Colitis · 2

P1147 Symptoms of irritable bowel syndrome are common in patients in remission from Inflammatory Bowel Disease: Results from an observational population-based cohort study in Norway

2024 · B Olsen, R Opheim, et al. · Journal of Crohn s and Colitis · 2

PDF

Anti-TNF withdrawal or long-term treatment in ulcerative colitis (BIOSTOP): a multicentre open label, randomized controlled trial

2026 · Ingrid Prytz Berset, Frode Lerang, et al. · Journal of Crohn s and Colitis · 1

Bacterial clusters are associated with the risk of severe disease progression in inflammatory bowel disease irrespective of conventional disease categories

2026 · Simen Hyll Hansen, Niharika Bhattacharjee, et al. · Microbiome Research Reports · 1

PDF

Disentangling the gut microbiome and inflammation in inflammatory bowel diseases: longitudinal observations from the IBSEN III study

2026 · Maria G Maseng, Simen H Hansen, et al. · Inflammatory Bowel Diseases · 1

OP04 NORDTREAT: a randomised, multicentre, biomarker-strategy design, open-label, controlled trial of top-down versus clinical management in newly diagnosed IBD

2026 · D Bergemalm, D Füchtbauer, et al. · Journal of Crohn s and Colitis · 1

P247 Anxiety and depression in newly diagnosed patients with Inflammatory Bowel Disease – Results from the IBSEN III study

2024 · I Johansen, M Hagen, et al. · Journal of Crohn s and Colitis · 1

PDF

P353 Ulcerative Colitis in the IBSEN III study: Frequent use of biologics and low colectomy rates first year of disease.

2023 · V Strande, C Lund, et al. · Journal of Crohn s and Colitis · 1

PDF

2026 · Bjorn Christian Olsen, Milada Hagen, et al. · Inflammatory Bowel Diseases

Works count: 48

Citation count: 200

H-index: 8

I10-index: 8